New spectacle lenses aim to halt worsening myopia in children

NCT ID NCT07394556

Not yet recruiting Disease control Sponsor: Indizen Optical Technologies, S.L.U. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether special spectacle lenses can slow the progression of myopia (nearsightedness) in European children aged 6 to 12. A total of 180 kids will wear one of three lens designs for two years. The main goal is to measure changes in eye length and prescription strength over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: myopia control spectacle lenses (Open Ring designs)
What this could lead to: If successful, these new lens designs could offer a better option to slow down worsening nearsightedness in children, reducing the need for stronger prescriptions.
What could go wrong: This is an early-stage trial with only 180 children, and results may not apply to all kids. The lenses might not slow myopia more than existing options, and long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA PROGRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA PROGRESSION

Contacts and locations

Locations

Hospital Universitario Clínico San Carlos

Madrid, Spain
Ulster University

Coleraine, United Kingdom
Universidade Do Minho

Braga, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.